Publicaciones en las que colabora con Daniel Carnevali Ruiz (7)

2023

  1. Outcomes and clinical characteristics of the compassionate use of plitidepsin for immunocompromised adult patients with COVID-19

    International Journal of Infectious Diseases, Vol. 135, pp. 12-17

2022

  1. Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019

    The Journal of infectious diseases, Vol. 226, Núm. 1, pp. 1-5

  2. Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia

    Journal of Hematology and Oncology

2021

  1. Cardiac magnetic resonance in recovering COVID-19 patients. Feature tracking and mapping analysis to detect persistent myocardial involvement

    IJC Heart and Vasculature, Vol. 36

  2. Cyclosporine A and COVID19 – The COQUIMA cohort – Author's reply

    EClinicalMedicine

2020

  1. COVID-19 and Metabolic Syndrome: NF-κB Activation. Crossroads

    Trends in Endocrinology and Metabolism

  2. Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)

    EClinicalMedicine, Vol. 28